Ten years of infliximab: Insights from clinical trials in rheumatoid arthritisSMOLEN, Josef S.European journal of pharmacology. 2009, Vol 623, issn 0014-2999, S5-S9, NSArticle

Infliximab therapy for patients with inflammatory bowel disease: 10 years onVAN ASSCHE, Gert; VERMEIRE, Séverine; RUTGEERTS, Paul et al.European journal of pharmacology. 2009, Vol 623, issn 0014-2999, S17-S25, NSArticle

Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's diseaseVAN ASSCHE, Gert; VANBECKEVOORT, Dirk; RUTGEERTS, Paul et al.The American journal of gastroenterology. 2003, Vol 98, Num 2, pp 332-339, issn 0002-9270, 8 p.Article

A Pooled Analysis of I nfections, Mal ignancy, and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel DiseaseLICHTENSTEIN, Gary R; RUTGEERTS, Paul; SANDBORN, William J et al.The American journal of gastroenterology. 2012, Vol 107, Num 7, pp 1051-1063, issn 0002-9270, 13 p.Article

Effects of anti-TNF-mAb treatment on pregnancy in baboons with induced endometriosisFALCONER, Henrik; MWENDA, Jason M; CHAI, Daniel C et al.Fertility and sterility. 2008, Vol 89, pp 1537-1545, issn 0015-0282, 9 p., SUP3Article